All In Biotech

Free tool

FAERS Monitor: Mycobutin

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050689 or its brand name (Mycobutin, Rifabutin). Reports on generic versions are filed under their own applications.

Reports

2,755

Serious

2,287

83% of reports

Hospitalization

977

Death reported

310

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug interaction270
  • drug ineffective268
  • off label use223
  • nausea171
  • pyrexia163
  • drug resistance161
  • mycobacterium avium complex infection150
  • drug intolerance129
  • neutropenia120
  • immune reconstitution inflammatory syndrome119
  • product use in unapproved indication109
  • diarrhoea100
  • dyspnoea95
  • vomiting95
  • fatigue89

Reports by year received

View as table
YearReports
200425
200525
200627
200727
200829
200959
201048
201159
201264
201342
201426
201564
201694
201799
2018173
2019135
2020152
2021168
2022206
2023297
2024344
2025390
2026202

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,404 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
mycobacterium avium complex infectionSignal150451.8384.863,285
immune reconstitution inflammatory syndromeSignal119186.8156.321,286
drug resistanceSignal16148.141.47,349
drug interactionSignal27013.011.63,000
drug intoleranceSignal12910.28.61,066
neutropeniaSignal1206.75.7584
pyrexiaSignal1633.63.1308
product use in unapproved indicationSignal1093.42.8180
off label use2231.91.7106
nausea1711.61.445
drug ineffective2681.61.456
vomiting951.51.318
dyspnoea951.31.16
diarrhoea1001.21.03
fatigue890.90.72

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.